Atlas Trials

Relapsed/Refractory CD19-positive B-ALL

1 clinical trials · Condition

Sort:Newest firstOldest first

◉ Watch Relapsed/Refractory CD19-positive B-ALL

RecordFirmDate
Clinical Study of Universal CD19 CAR-γδ T Cell Infusion in the Treatment of Relapsed/Refractory Acute B Lymphoblastic Leukemia (NCT07491263)Fujian Medical University2026-05-01

Track Relapsed/Refractory CD19-positive B-ALL automatically

Every clearance here is in the API, with alerts when new ones post.